U.S. patent number 5,080,902 [Application Number 07/212,993] was granted by the patent office on 1992-01-14 for article and a prophylactic composition containing a microbicide.
This patent grant is currently assigned to Berol Kemi AB. Invention is credited to Stig Allenmark, Lars Edebo, Magnus Lindstedt.
United States Patent |
5,080,902 |
Allenmark , et al. |
* January 14, 1992 |
Article and a prophylactic composition containing a microbicide
Abstract
A prophylactic agent for controlling venereal diseases. As an
active microbicidal component, the agent has an ammonium compound
having hydrolyzable ester group.
Inventors: |
Allenmark; Stig (Kullavik,
SE), Lindstedt; Magnus (Gothenburg, SE),
Edebo; Lars (Gothenburg, SE) |
Assignee: |
Berol Kemi AB (Stenungsund,
SE)
|
[*] Notice: |
The portion of the term of this patent
subsequent to December 13, 2005 has been disclaimed. |
Family
ID: |
26659200 |
Appl.
No.: |
07/212,993 |
Filed: |
June 29, 1988 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
948261 |
Dec 31, 1986 |
4790978 |
Dec 13, 1988 |
|
|
Foreign Application Priority Data
|
|
|
|
|
Jan 7, 1986 [SE] |
|
|
8600046 |
Jun 29, 1987 [SE] |
|
|
8702674 |
|
Current U.S.
Class: |
424/430; 128/842;
128/844; 422/28; 424/431; 424/432; 424/433; 424/DIG.14; 514/556;
514/642; 514/841; 514/931 |
Current CPC
Class: |
A01N
37/44 (20130101); A61K 31/22 (20130101); Y10S
514/841 (20130101); Y10S 424/14 (20130101); Y10S
514/931 (20130101) |
Current International
Class: |
A01N
37/44 (20060101); A61K 31/21 (20060101); A61K
31/22 (20060101); A61F 006/00 (); A61K
031/14 () |
Field of
Search: |
;128/844
;424/DIG.14,430-433 ;514/556,642 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
0190797 |
|
Aug 1986 |
|
EP |
|
1061457 |
|
Mar 1967 |
|
GB |
|
Other References
M Metayer, Ann. Pharm. Franc., 10 (1952), pp. 435-439. .
T. Nakamiya et al., "Antibacterial Activity of Lauryl Esters of
DL-Lysine", Ferment Tech., vol. 54, No. 6, (1976), pp. 369-373.
.
A. E. Epsstein et al., "Bactericidial Quaternary Ammonium Salts
Derived from Monochloro-Acetate Esters", Khim. Farm. Zh., vol. 14,
No. 23, (1980), pp. 292-295. .
Khim.-Farm. Zh., vol. 14, No. 5 (1980), pp. 23-26. .
Chemical Abstracts, vol. 93 (1980), 113917t (Abs. of Ref. Ar
herein). .
Nakamiya et al., "Antibacterial Activity . . . ", J. Ferm. Techn.,
vol. 54, (1976), pp. 369-373. .
Bundesverebandder Pharmazeutischeal Industry, "Rote Liste
1977/1978", Preparations Nos. 45125B and 45126B..
|
Primary Examiner: Page; Thurman K.
Assistant Examiner: Spear; James M.
Attorney, Agent or Firm: Spencer & Frank
Parent Case Text
CROSS-REFERENCE TO RELATED APPLICATION
This application is a continuation-in-part of Ser. No. 06/948,261
filed Dec. 31st, 1986 which issued as U.S. Pat. No. 4,790,978 on
Dec. 13th, 1988 .
Claims
What is claimed is:
1. The process of preventing the spread of gonorrhea and chlamydia
among mammals, comprising:
applying an article topically to an appropriate bodily portion of a
mammal, the article being a hygienic product comprised of a
prophylactic composition containing at least one microbicide in an
amount effective for controlling at least one of gonorrhea and
chlamydia, which at least one microbicide is hydrolyzable at a pH
value ranging from about 6 to about 8.5 and is an ammonium compound
having the general formula ##STR5## wherein R.sup.I, R.sup.II and
R.sup.III are hydrogen or lower alkyl groups having 1 to 4 carbon
atoms, R.sup.IV is a long chain alkyl group having 10 to 18 carbon
atoms, R.sup.V is hydrogen or a group having the formula R.sup.VI
N.sup.+ H.sub.3, R.sup.VI is an alkylene group having 3 to 4 carbon
atoms, A is a monovalent counter ion, and n is the number of
cationic groups in the ammonium compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
2. The process of preventing the spread of herpes and AIDS among
mammals, comprising:
applying an article topically to an appropriate bodily portion of a
mammal, the article being a hygienic product comprised of a
prophylactic composition containing at least one microbicide in an
amount effective for controlling at least one of herpes and AIDS,
which at least one microbicide is hydrolyzable at a pH ranging from
about 6 to about 8.5 and is an ammonium compound having the general
formula ##STR6## wherein R.sup.I, R.sup.II and R.sup.III are
hydrogen or lower alkyl groups having 1 to 4 carbon atoms, R.sup.IV
is a long chain alkyl group having 10 to 18 carbon atoms, R.sup.V
is hydrogen or a group having the formula R.sup.VI N.sup.+ H.sub.3,
R.sup.VI is an alkylene group having 3 to 4 carbon atoms, A is a
monovalent counter ion, and n is the number of cationic groups in
the ammonium compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
3. The process of preventing the spread of gonorrhea and chlamydia
among mammals, comprising:
applying a prophylactic composition topically to an appropriate
bodily portion of a mammal, the prophylactic composition being
comprised of at least one microbicide present in an amount
effective for controlling at least one of gonorrhea and chlamydia,
which at least one microbicide is hydrolyzable at a pH value
ranging from about 6 to about 8.5 and is an ammonium compound
having the general formula ##STR7## wherein R.sup.I, R.sup.II and
R.sup.III are hydrogen or lower alkyl groups having 1 to 4 carbon
atoms, R.sup.IV is a long chain alkyl group having 10 to 18 carbon
atoms, R.sup.V is hydrogen or a group having the formula R.sup.VI
N.sup.+ H.sub.3, R.sup.VI is an alkylene group having 3 to 4 carbon
atoms, A is a monovalent counter ion, and n is the number of
cationic groups in the ammonium compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
4. The process of preventing the spread of herpes and AIDs among
mammals, comprising:
applying a prophylactic composition topically to an appropriate
bodily portion of a mammal, the prophylactic composition being
comprised of at least one microbicide present in an amount
effective for controlling at least one of herpes and AIDS, which at
least one microbicide is hydrolyzable at a pH ranging from about 6
to about 8.5 and is an ammonium compound having the general formula
##STR8## wherein R.sup.I, R.sup.II and R.sup.III are hydrogen or
lower alkyl groups having 1 to 4 carbon atoms, R.sup.IV is a long
chain alkyl group having 10 to 18 carbon atoms, R.sup.V is hydrogen
or a group having the formula R.sup.VI N.sup.+ H.sub.3, R.sup.VI is
an alkylene group having 3 to 4 carbon atoms, A is a monovalent
counter ion, and n is the number of cationic groups in the ammonium
compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
5. The process of preventing the spread of gonorrhea, chlamydia,
herpes and AIDS among mammals, comprising:
applying an article topically to an appropriate bodily portion of a
mammal, the article being a hygienic product selected from the
group consisting of a condom, vaginal pad, tampon, napkin, mask and
diaper, and being comprised of a prophylactic composition
containing at least one microbicide in an amount effective for
controlling at least one of gonorrhea, chlamydia, herpes and AIDS,
which at least one microbicide is hydrolyzable at a pH value
ranging from about 6 to about 8.5 and is an ammonium compound
having the general formula ##STR9## wherein R.sup.I, R.sup.II and
R.sup.III are hydrogen or lower alkyl groups having 1 to 4 carbon
atoms, R.sup.IV is a long chain alkyl group having 10 to 18 carbon
atoms, R.sup.V is hydrogen or a group having the formula R.sup.VI
N.sup.+ H.sub.3, R.sup.VI is an alkylene group having 3 to 4 carbon
atoms, A is a monovalent counter ion, and n is the number of
cationic groups in the ammonium compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
6. The process of preventing the spread of gonorrhea, chlamydia,
herpes and AIDS among mammals, comprising:
applying a prophylactic composition topically to an appropriate
bodily portion of a mammal, the prophylactic composition being
comprised of at least on microbicide present in an amount effective
for controlling at least one of gonorrhea, chlamydia, herpes and
AIDS, and having a form selected from the group consisting of a
spray, ointment, foam, gel, tablet, powder and solution, which at
least one microbicide is hydrolyzable at a pH value ranging from
about 6 to about 8.5 and is an ammonium compound having the general
formula ##STR10## wherein R.sup.I, R.sup.II and R.sup.III are
hydrogen or lower alkyl groups having 1 to 4 carbon atoms, R.sup.IV
is a long chain alkyl group having 10 to 18 carbon atoms, R.sup.V
is hydrogen or a group having the formula R.sup.VI N.sup.+ H.sub.3,
R.sup.VI is an alkylene group having 3 to 4 carbon atoms, A is a
monovalent counter ion, and n is the number of cationic groups in
the ammonium compound; and
allowing the ammonium compound to be hydrolyzed by exposure to a pH
ranging from about 6 to about 8.5.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention refers to a prophylactic agent for
controlling venereal diseases, said agent containing, as an active
microbicidal component, an ammonium compound having a hydrolyzable
ester bond.
2. Description of the Related Art
For a long time it has been known that a number of venereal
diseases, such as gonorrhoea and chlamydia, are spread by sexual
contact. These diseases are caused by bacteria. In later years also
venereal diseases caused by viruses, such as AIDS (Acquired Immune
Deficiency Syndrome) and herpes, have gotten increasing attention.
For prophylactic purposes, the use of condoms, foams, ointments,
gels and other products are recommended onto which have been
applied or which contain microbicidal compounds. The microbicidal
compounds which have been used, however, have the disadvantage that
they cause a persistent irritation after use.
Amphiphilic compounds of the quaternary ammonium type have been
long known to exhibit a strong antimicrobial activity; the
disclosure by Domagk in 1935 having had great impact on the
development of this field. (G. Domagk, Dtsch. Med. Wochenschr. 61,
829 (1935). It has become evident, however, from studies of acute,
as well as chronic toxicity, that these compounds may give rise to
skin irritation and hypersensitivity, and, therefore, are not
recommended for certain applications.
SUMMARY OF THE INVENTION
Therefore, it is an object of this invention to find antimicrobial
compounds which do not have the drawback mentioned above. Another
object of the invention is to permit a rapid inactivation by a
controllable degradation of the antimicrobial compound. Still
another object is that the degradation will take place at a pH
value from about 6 to about 8.5, which is a pH value that does not
give raise to skin irritation and the like. Also, a still further
object is to provide a prophylactic agent for controlling venereal
diseases caused by bacteria or viruses which contains or has
applied onto it one or more antimicrobial compounds which do not
exhibit the drawback mentioned above.
It has now been shown that the above objects are met by a
prophylactic agent, which contains or has been treated with a
long-chain ammonium compound having the general formula ##STR1##
wherein R.sup.I, R.sup.II and R.sup.III are hydrogen or lower alkyl
groups, and R.sup.IV is a long chain alkyl group having 10 to 18
carbon atoms, R.sup.V is hydrogen or a group having the formula
R.sup.VI N.sup.+ H.sub.3, wherein R.sup.VI is an alkylene group
having 3 to 4 carbon atoms, A is a monovalent counter ion, and n is
the number of cationic groups in the compound, and has good
activity against microorganisms which cause a number of the most
common venereal diseases, such as gonorrhoea and chlamydia.
Especially surprising and valuable is the fact that the ammonium
compound also has a good effect on viruses which cause venereal
diseases. Examples of such viruses are herpes simplex virus, human
immunodeficiency virus (AIDS virus), and human papilloma virus. It
is thus also possible to control AIDS and herpes.
It is important that the ester bond of the ammonium compound is
hydrolyzable at a neutral pH or above. The pH of the vagina is low,
however, usually within the range 2-4, and within this range the
ammonium compounds are stable and are able to kill bacteria and
viruses in the vaginal lumen. At the vaginal wall, however, the pH
value increases significantly, and when the ammonium compound
contacts the tissues of the wall, its ester bond is hydrolyzed and
the ammonium compound is transformed into inactive, harmless
products, whereby a residual microbicidal irritation after use of
the prophylatic agent of the invention is avoided. This is a very
important feature when the compounds are to be used in prophylactic
agents against venereal diseases.
The lower alkyl groups R.sup.I, R.sup.II and R.sup.III preferably
are alkyl groups having 1-4 carbon atoms, and most preferably they
are methyl groups. Preferably R.sup.IV is a straight chain alkyl
group. The counter ion A is usually a halide ion, such as chloride,
or HSO.sub.4 -.
Examples of lower alkyl groups are methyl, ethyl, propy, isopropyl,
butyl, secondary butyl and isobutyl, but ethyl and especially
methyl are preferred. The long-chain alkyl group R.sup.IV can be
decyl, dodecyl, dodecenyl, tetradecyl, hexadecyl, octadecyl,
octadecenyl, octadecadienyl and oktadecatrienyl. Among these
groups, the saturated groups are especially preferred.
Examples of preferred ammonium compounds are compounds having the
formulae ##STR2## wherein R.sup.IV and A have the meanings stated
above.
The ammonium compounds described above have previously been
disclosed in the chemical literature (I. Metayer, Ann. pharm.
franc. 10, 435, 439 (1952) and they have also been shown to have
antibacterial properties (A. E. Epstein et al., Khim. Farm. Zh. 14,
23 (1980) and Teruaki Nakamiya et al., Ferment. Technol. Vol. 54
nr. 6, p. 369-376 (1976). None of these reports discloses, however,
that the ammonium compounds in question have a microbicidal effect
against bacteria and viruses which cause venereal diseases. Also,
there is no disclosure that the compounds hydrolyze rapidly at pH
values of about 6 to 8.5, forming non-irritating hydrolysis
products.
When an antimicrobial agent is used at appropriate concentration
levels, the time needed for full antimicrobial effect is generally
fairly short. In most practical situations, the antimicrobial agent
is also administrated in a very large excess. Therefore, in many
applications the toxic compound is active for a long time after it
has exerted its antimicrobial action, which is both undesirable and
unnecessary. The invention discloses a principle, according to
which the antimicrobial compound loses its biological activity and
toxic action by a hydrolytic reaction. The rate of hydrolysis can
be regulated by small changes of pH and electrolyte concentration
leading to harmless end products within the physiologically
suitable pH range of from about 6 to about 8.5.
The solubility of the esters in polar organic solvents, such as
lower alcohols, and alcohol/water mixtures is of the order 1 g/ml.
Such formulations are highly stable and allow long-term
storage.
The esters are highly active against a broad spectrum of Gram
positive, as well as Gram negative, bacteria and examples of test
data are given below. An important and quite unexpected feature of
the invention is also that the compounds have a pronounced effect
on viruses which cause venereal diseases.
The temporary disinfecting effect of the esters may be used in
hygienic products, such as diapers, tampons, masks, napkins, and
cosmetic powders. It may also be employed as disinfectants in,
e.g., bubble baths, swimming pools, mouthwashes; and for treatment
of packages, food etc. The esters can be applied on webs and
garments by dipping into or spraying thereon a slightly acid,
aqueous solution of the ester, followed by a rapid drying.
Cellulosic fibers may be impregnated by adding the esters to the
cellulose pulp slurry in the head-box. When used in dry form, the
esters may have the form of a tablet, for example, an effervescent
tablet. In an important application of the invention, the esters
are applied to or incorporated into prophylactic agents for
preventing the spreading of venereal diseases.
The esters may be prepared according to conventional methods by
reacting a chloro- or bromoacetyl halide with an alcohol in a
halogenated hydrocarbon to provide an alkyl chloro- or
bromoacetate. This ester is then converted into the ester of a
betaine by reaction with gaseous trialkyalamine in a solvent, such
as acetone or toluene.
The ammonium compounds can, in a way known per se, be mixed into or
applied to agents for controlling the spread of venereal diseases.
Such agents can be sprays, ointments, gels, foams, condoms and
vaginal pads. As the ammonium compounds are hydrolyzed at neutral
and basic pH, they are usually added in the form of an acidic
aqueous solution or alternatively, as a solution based on an
organic solvent. When the prophylatic agent is a condom or vaginal
pad, the ammonium compound is applied by dipping the prophylatic
agent in or spraying it thereon as a solution containing the
ammonium compound and subsequent drying. If the prophylatic agent
is aqueous, its pH value should be lower than 5.
The prophylatic agent according to the invention would be useful
for preventing the spread of various venereal diseases not just
among human beings, but among mammals in general who are subject to
such diseases. Further, the prophylactic agent according to the
invention may be topically applied to the genitals of males or
females of the mammal to be protected and, moreover, may be
topically applied to any appropriate bodily portion of the mammal
through which the microbes may enter the host, such as to mucous
membranes.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The invention is further illustrated by the following examples.
EXAMPLE 1
The bactericidal effect of three esters having the following
formula
where p was 10, 12 and 14 respectively, were determined and
compared with cetyltrimetylammonium bromide (CTAB), a well-known
bactericide. The effect was measured as the concentration needed
for reducing the number of viable bacteria by a factor of 10.sup.5
using E. coli (NCTC 10418) as the test organism during a 5 minute
contact time. The results are shown in the Table below.
TABLE 1 ______________________________________ Compound
Concentration p ppm ______________________________________ 10 50 12
12.5 14 >100 CTAB 12.5
______________________________________
From these results it is evident that the material tested have
appropriate bactericidal effect.
EXAMPLE 2
The activity towards a series of microorganisms was determined for
the compound in Example 1 having 14 carbon atoms all together in
its alkyl chain (p=12). Relevant test data are given in the Table
below. The activity is expressed as log (cfu/ml) at a 12.5 ppm
level and a 5 min contact time in phosphate buffered saline at room
temperature. Effects are related to a control (without bactericide)
and to CTAB. G+ and G- denote Gram positive and Gram negative
species, respectively.
TABLE 2 ______________________________________ log (cfu/mol)
betaine Microorganisms (Type) control ester CTAB
______________________________________ Bacillus megaterium (G+) 6.7
<3.3 <3.3 E. Coli (G-) 7.0 <3.3 <3.3 Candida albicans
(yeast) 6.2 6.2 5.7 Pseudomonas aeruginosa (G-) 7.4 7.5 7.5
Staphylococcus aureus (G+) 5.8 <3.3 <3.3 Salmonella
typhimurium (G-) 5.5 3.9 3.8
______________________________________
The effects of the betaine ester and of CTAB are the same within
experimental error. Except against the more resistant Ps.
aeruginosa and the yeast C. albicans, high activities are found
even at these low concentrations.
EXAMPLE 3
The rate of alkaline hydrolysis of the present esters of betaines
was determined for the compound in example 1 having 14 carbon atoms
in its alkyl chain all together (p=12). The conditions during the
test and results obtained are given in the Table below.
TABLE 3 ______________________________________ Hydrolysis (given in
%) at various pH values and reaction times at 30.degree. C. time pH
hrs 2.6 3 4 5 6 7 8 9 ______________________________________ 0.25
96 0.5 12 100 1 5 60 100 1.5 87 2 2 10 3 100 4 37 100 8 <1 <1
1 80 18 16 20 98 24 <1 2 3 5 46 85 48 <1 2 5 10 120 144 1 6
12 22 ______________________________________
The rate of hydrolysis is also temperature dependent. Upon a
temperature increase from 25.degree. C. to 30.degree. C. the
half-life at pH 7.0 is decreased from 9 to 5 hrs.
EXAMPLE 4
The rate of hydrolysis and, thereby, the duration of the biological
activity of the esters can also be regulated according to this
invention by the salt concentration of the medium. The rate of
hydrolysis is decreased considerably by an increase in sodium
chloride concentration. In the Table below, the effect of sodium
chloride on hydrolysis of the compound in Example 2 at a pH 7.9 and
30.degree. C. is shown.
TABLE 4 ______________________________________ Hydrolysis, %
Molarity of NaCl t, hrs 0 0.1 0.5 1.0
______________________________________ 1 51 9 6 2 2 95 56 9 4 5 100
100 28 12 48 95 77 ______________________________________
EXAMPLE 5
A solution of 150 ppm of the compound in Example 1 in 10 mM
phsophate buffer, pH 8.0, was analyzed at different points in time
with respect to degree of hydrolysis, as well as bactericidal
effect against E. coli (NCTC 10418). The degree of hydrolysis was
determined by analysis of the liberated 1-tetradecanol by gas
chromatography (packed 4 ft glass column with 3% SP-2100 on 80/100
Supelcoport; isotermally at 130.degree. C.). The 1-tetradecanol was
isolated by careful extraction with hexane. Internal
standardization was carried out by means of 1-hexadecanol.
Bactericidal effect was determined by dilution of a 1 ml sample to
25 ppm with 5 ml of a sterile buffer, followed by addition of 60
.mu.l of the bacterial suspension. After 5 min at room temperature,
a 100-fold dilution and spreading on an agar plate using a Spiral
Plater system was performed. The plates were incubated at
37.degree. C. for 20 hrs and counted. Data from the experiments are
given in the Table below.
TABLE 5 ______________________________________ Hydrolysis and the
effect on the bacterial activity. Viable counts, cfu/ml Time, min
Hydrolysis, % (control: 7.1 .times. 10.sup.6)
______________________________________ 5 0 23 3 30 4.1 .times.
10.sup.3 64 25 109 3.0 .times. 10.sup.6 118 55 149 86 158 7.9
.times. 10.sup.6 179 89 199 7.8 .times. 10.sup.6 217 100 238 100
______________________________________
EXAMPLE 6
The effect of the following ammonium compounds on gonococci at a
concentration of 30 ppm in an 0.01M citrate solution with a pH
value of 6 was determined after 1 and 10 minutes. The following
results were obtained.
______________________________________ Gonococci log cfu/ml
Compound 0 min 1 min 10 min ______________________________________
##STR3## 10.sup.6 <10.sup.1 <10.sup.1 (CH.sub.3).sub.3
NCH.sub.2 COOC.sub.16 H.sub.33 Cl- 10.sup.6 <10.sup.1
<10.sup.1 ##STR4## 10.sup.6 <10.sup.3 <10.sup.1
______________________________________
EXAMPLE 7
The effect of (CH.sub.3).sub.3 NCH.sub.2 COOC.sub.14 H.sub.29
Cl.sup.- in an 0.01M citrate solution on herpes simplex virus was
examined. The concentration of the ammonium compound was 20 ppm.
After 10 minutes, the concentration of virus had been reduced by a
factor greater than 10.sup.3.
The present disclosure relates to the subject matter disclosed in
Swedish Patent Application No. 8600046-0 filed Jan. 7th, 1986 and
Swedish Patent Application No. 8702674-6, filed June 29th, 1987,
the entire specifications of which are incorporated herein by
reference.
It will be understood that the above description of the present
invention is susceptible to various modifications, changes and
adaptations, and the same are intended to be comprehended within
the meaning and range of equivalents of the appended claims.
* * * * *